Huons Co., Ltd. (KOSDAQ:243070)

Market Cap	330.30B
Revenue (ttm)	595.36B
Net Income (ttm)	34.97B
Shares Out	11.65M
EPS (ttm)	2,909.22
PE Ratio	9.74
Forward PE	n/a
Dividend	630.00 (2.19%)
Ex-Dividend Date	Nov 24, 2025

Volume	16,540
Average Volume	36,974
Open	28,450
Previous Close	28,350
Day's Range	28,450 - 29,200
52-Week Range	21,800 - 32,200
Beta	0.07
RSI	48.50
Earnings Date	Nov 9, 2025

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2024, Huons's revenue was 590.23 billion, an increase of 6.92% compared to the previous year's 552.01 billion. Earnings were 29.45 billion, a decrease of -41.64%.